Mengwan Wu
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 6
- Inflammatory Biomarkers in Disease Prognosis 2
- HER2/EGFR in Cancer Research 2
-
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Lihong Guo (5 shared papers)Qiang Zuo (6 shared papers)Jing Guo (2 shared papers)Chuan Xu (8 shared papers)Changqie Pan (1 shared paper)Sheng Peng (1 shared paper)Jing Guo (1 shared paper)Jing Liu (1 shared paper)
- Journals
- CNS Neuroscience & Therapeutics (2 papers)Journal of Clinical Oncology (1 paper)Journal of Hematology & Oncology (1 paper)Life (1 paper)Hepatology (1 paper)
- Partner nations
- ChinaHong KongSouth Sudan
In The Last Decade
Mengwan Wu
18 papers receiving 426 citations
Peers
Comparison fields: 5 of 62
- Oncology 166
- Cancer Research 68
- Otorhinolaryngology 17
- Immunology 52
- Radiology, Nuclear Medicine and Imaging 53
Countries citing papers authored by Mengwan Wu
This map shows the geographic impact of Mengwan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengwan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengwan Wu more than expected).
Fields of papers citing papers by Mengwan Wu
This network shows the impact of papers produced by Mengwan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengwan Wu. The network helps show where Mengwan Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengwan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 99 | |
| 2 | 2016 | 86 | |
| 3 | 2015 | 52 | |
| 4 | 2020 | 28 | |
| 5 | 2022 | 28 | |
| 6 | 2023 | 27 | |
| 7 | 2021 | 19 | |
| 8 | 2022 | 17 | |
| 9 | 2024 | 15 | |
| 10 | 2023 | 15 | |
| 11 | 2022 | 15 | |
| 12 | 2024 | 11 | |
| 13 | 2017 | 9 | |
| 14 | 2022 | 3 | |
| 15 | 2020 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2016 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2023 | 0 |
About Mengwan Wu
Mengwan Wu is a scholar working on Oncology, Molecular Biology, Immunology, Otorhinolaryngology and Genetics, having authored 19 papers that have together received 430 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (3 papers), Glioma Diagnosis and Treatment (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Immunotherapy and Immune Responses (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immune cells in cancer (2 papers), HER2/EGFR in Cancer Research (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Oncology (166 citations), Cancer Research (68 citations), Otorhinolaryngology (17 citations), Immunology (52 citations) and Radiology, Nuclear Medicine and Imaging (53 citations). Mengwan Wu has collaborated with scholars based in China, Hong Kong and South Sudan. Frequent co-authors include Lihong Guo, Qiang Zuo, Jing Guo, Chuan Xu, Changqie Pan, Sheng Peng, Jing Guo, Jing Liu, Qianying Wu and Ying Shi. Their work appears in journals such as CNS Neuroscience & Therapeutics, Journal of Clinical Oncology, Journal of Hematology & Oncology, Life and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.